Cerebral Palsy Stem Cell Therapy Abroad: A Guide for Families in the Netherlands & UAE

A coordination guide for families in the Netherlands and UAE exploring stem cell therapy for cerebral palsy abroad. Regulation at home, how a treatment episode fits alongside intensive rehabilitation, travel logistics, costs, and realistic expectations. StemCell Longevita is an international patient coordination platform, not a treatment provider.

Why Dutch and UAE Families Look Abroad for Cerebral Palsy Care

Both the Netherlands and the United Arab Emirates offer strong rehabilitation for cerebral palsy — Dutch families through paediatric rehabilitation centres (revalidatiecentra), physiotherapy, occupational therapy, and specialist paediatric neurology; UAE families through a growing network of private rehabilitation clinics and specialist centres. What neither offers as a routine, reimbursed pathway is mesenchymal stem cell (MSC) therapy, leading some parents to research treatment abroad as a possible adjunct to rehabilitation.

StemCell Longevita's Role and the Central Importance of Rehabilitation

StemCell Longevita is an international patient coordination platform based in Istanbul. We are not a treatment provider, we do not diagnose cerebral palsy, and we do not promise recovery. MSC therapy does not reverse the brain injury that causes CP. The research rationale is that MSCs may reduce chronic neuroinflammation and support surviving neural tissue, creating a more favourable environment in which intensive rehabilitation can work. This is why we require families to maintain — and ideally intensify — physiotherapy and occupational therapy around treatment. Reported outcomes vary widely and are often modest; no one can promise a child will walk or talk.

Regulation, Travel and Cost for the Netherlands and UAE

MSC therapy for cerebral palsy is not approved or reimbursed in the Netherlands under EU/EMA rules and is not an approved indication in the UAE. Istanbul is roughly 3.5 hours from Amsterdam and 4.5 hours from Dubai or Abu Dhabi, with English and Dutch consultation, Arabic-speaking coordination support, and wheelchair-accessible transfers arranged in advance. A typical stay is 5–7 days. Coordinated treatment is typically 60–80% less than comparable private clinics in Western Europe, quoted individually after medical review. Families should keep their Dutch revalidatiecentrum or Emirati rehabilitation clinic informed and continue therapy at home.

Frequently Asked Questions

How does stem cell therapy help cerebral palsy?

MSCs reduce neuroinflammation, promote neural repair, improve blood flow to damaged brain areas, and support formation of new neural connections. Children often show improvements in motor function, muscle tone, speech, and cognitive abilities.

At what age can children receive stem cell therapy for cerebral palsy?

Children as young as 1 year old can safely receive MSC therapy for CP. Earlier treatment is generally associated with better outcomes, as the developing brain has greater neuroplasticity and capacity for recovery.

What improvements can cerebral palsy patients expect?

Families commonly report improved motor control, reduced spasticity, better balance, enhanced speech and communication, improved cognitive function, and greater independence in daily activities within 2-6 months of treatment.

Is stem cell therapy safe for children with cerebral palsy?

Yes. Wharton's jelly-derived MSCs have an excellent safety profile in pediatric patients. Our clinic has treated hundreds of children with CP without serious adverse events. The cells are immunoprivileged and do not require HLA matching.

Related articles: Stem Cell Therapy for Cerebral Palsy (2026 Guide) | Stem Cell Treatment for Newborn Brain Damage: Hope for Neonatal Recovery | Autism Stem Cell Therapy Abroad: A Guide for Families in the Netherlands & UAE

Related treatments: Cerebral Palsy Stem Cell Therapy | Stem Cell Therapy for Autism